Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|18|1|245-252

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.18, Iss.1, 2018-01, pp. : 245-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 536-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

Falsely decreased ionized calcium levels in kidney transplant recipients with polyomavirus‐associated nephropathy treated with leflunomide

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 874-875

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Polyomavirus BK Monitoring by Quantitative PCR in Renal Transplant Recipients

By  

Intervirology, Vol. 47, Iss. 1, 2004-03 ,pp. : 41-47

Karger

Access to resources Recommend Favorite

The Risk of End‐Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 1600-6135, Iss. 10, 2015-10 ,pp. : 2732-2738

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Risk of End‐Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 10, 2015-10 ,pp. : 2732-2738

John Wiley & Sons Inc

Access to resources Recommend Favorite